Who Buys Gliclazide from India — 643 Importers Behind a $300.8M Market
India's gliclazide import market is served by 643 active buyers who collectively imported $300.8M across 3,830 shipments. MYLAN HUNGARY KFT, (HUNGARY) leads with a 28.9% market share, followed by DANANG PHARMACEUTICAL MEDICAL EQUIP and TORRENT DO BRASIL LTDA. The top 5 buyers together control 44.0% of total import value, reflecting a moderately competitive buyer landscape.
Top Gliclazide Importers — Ranked by Import Value
MYLAN HUNGARY KFT, (HUNGARY) is the leading gliclazide importer from India, holding a 28.9% share of the $300.8M market across 3,830 shipments from 643 buyers. The top 5 buyers — MYLAN HUNGARY KFT, (HUNGARY), DANANG PHARMACEUTICAL MEDICAL EQUIP (VIETNAM), TORRENT DO BRASIL LTDA (BRAZIL), MYLAN PHARMACEUTICALS ULC (CANADA), DELTA IMPORT EXPORT MEDICAL CO., LT (VIETNAM) — collectively control 44.0% of total import value.
Top Gliclazide Buyers & Importers
Ranked by import value · 643 active buyers · Indian Customs (DGFT) data
| # | Buyer & Formulations | Value | Suppliers | Share |
|---|---|---|---|---|
| 1 | MYLAN HUNGARY KFT,HUNGARY GLICLAZIDE TABLETS 80 MGGLICLAZIDE MODIFIED RELEASE TABLETS 30 MGMYLAN GLICLAZIDE MR 30MG TAB 100BT PACKS22680 | $87.1M | 5 | 28.9% |
| 2 | DANANG PHARMACEUTICAL MEDICAL EQUIPVIETNAM GLIZYM M TABLETS B/N.18423023 TOGLIZYM M TABLETS B/N.18423026 TOHARMLESS MEDICINES : GLYCINORM 80MG TABLETS ] [PACK:3X10'S] | $31.3M | 5 | 10.4% |
| 3 | TORRENT DO BRASIL LTDABRAZIL AZUKON MR TABLET ( GLICLAZIDE MODIFIED RGLICLAZIDE SUN TAB 30MG 20X50BBR PAGLICLAZIDE TAB 60 MG 50X10B PACK:BOX50X1 | $6.5M | 5 | 2.2% |
| 4 | MYLAN PHARMACEUTICALS ULCCANADA GLICLAZIDE TABLETS 80 MGGLICLAZIDE MODIFIED RELEASE TABLETS 30 MGMYLAN GLICLAZIDE MR 30MG TAB 100BT PACKS22680 | $4.1M | 5 | 1.4% |
| 5 | DELTA IMPORT EXPORT MEDICAL CO., LTVIETNAM GLIZYM M TABLETS B/N.18423023 TOGLIZYM M TABLETS B/N.18423026 TOHARMLESS MEDICINES : GLYCINORM 80MG TABLETS ] [PACK:3X10'S] | $3.4M | 5 | 1.1% |
| 6 | CENTRAL PHARMACEUTICAL JOINT STOCKVIETNAM GLIZYM M TABLETS B/N.18423023 TOGLIZYM M TABLETS B/N.18423026 TOHARMLESS MEDICINES : GLYCINORM 80MG TABLETS ] [PACK:3X10'S] | $3.2M | 5 | 1.1% |
| 7 | MEDREICH PLCUNITED KINGDOM GLICLAZIDE 40MG TABLETS 28'SGLICLAZIDE 80MG TABLETS 2X14SPHARMACEUTICAL PRODUCTS - GLICLAZIDE 80MG TABLETS | $3.1M | 5 | 1.0% |
| 8 | M/S. RANBAXY FARMACEUTICA LTDA :BRAZIL GLIZID M TABLETS B/N.01823003 M/MYLAN GLICLAZIDE MR 30MG TAB 100BT PACKS22680AZUKON MR TABLET ( GLICLAZIDE MODIFIED R | $2.4M | 5 | 0.8% |
| 9 | RANBAXY FARMACEUTICA LTDA :BRAZIL AZUKON MR TABLET ( GLICLAZIDE MODIFIED RGLICLAZIDE SUN TAB 30MG 20X50BBR PAGLICLAZIDE TAB 60 MG 50X10B PACK:BOX50X1 | $2.3M | 5 | 0.8% |
| 10 | FIEGE HEALTHCARE LOGISTICS GMBHGERMANY GLICLAZIDE MR TAB 60MG 30 SANDOZ FRANCE | $2.2M | 5 | 0.7% |
| 11 | SUN PHARMA CANADA INC.CANADA MYLAN GLICLAZIDE MR 30MG TAB 100BT PACKS22680AZUKON MR TABLET ( GLICLAZIDE MODIFIED RGLICLAZIDE SUN TAB 30MG 20X50BBR PA | $1.9M | 5 | 0.6% |
| 12 | TORRENT DO BRASIL LIMITEDABRAZIL AZUKON MR TABLET ( GLICLAZIDE MODIFIED RGLICLAZIDE SUN TAB 30MG 20X50BBR PAGLICLAZIDE TAB 60 MG 50X10B PACK:BOX50X1 | $1.6M | 5 | 0.5% |
| 13 | SOHACO TRADING AND PHARMACEUTICALVIETNAM GLIZYM M TABLETS B/N.18423023 TOGLIZYM M TABLETS B/N.18423026 TOHARMLESS MEDICINES : GLYCINORM 80MG TABLETS ] [PACK:3X10'S] | $1.3M | 5 | 0.4% |
| 14 | STATE PHARMACEUTICALS CORPORATION OSRI LANKA 63619 PACKS OF GLICLAZIDE MODIFIED RELEAGLITROL CR 60 (GLICLAZIDE CONTROLLED REL | $1.2M | 5 | 0.4% |
| 15 | CRESCENT PHARMA LIMITEDUNITED KINGDOM GLICLAZIDE 40MG TABLETS 28'SGLICLAZIDE 80MG TABLETS 2X14SPHARMACEUTICAL PRODUCTS - GLICLAZIDE 80MG TABLETS | $1.2M | 5 | 0.4% |
Related Analysis
Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Which companies are buying Gliclazide — and from which countries?
Flow of Gliclazide exports from India: each country's share and the named importers behind the numbers
Gliclazide — Buyer Countries to Key Importers
Trade flow: top importing countries → named buyer companies
Market Analysis: Top Importing Countries & Their Importers
1Hungary
Hungary emerges as the first largest importing country, achieving a total trade value of $88.2M through 21 shipments. This represents a market share of 29.3% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Hungary has a diverse importer base, with their top importers including:
• MYLAN HUNGARY KFT, - $87.1M (98.8% of country's total business)
Key Insight: Hungary demonstrates strong market positioning with an average shipment value of $4.2M, indicating premium pricing strategy compared to the market average of $78.5K.
Hungary is a key market for Gliclazide imports, representing 29.3% of total trade value.
2Netherlands
Netherlands emerges as the second largest importing country, achieving a total trade value of $87.7M through 0 shipments. This represents a market share of 29.2% of the total market activity, demonstrating their significant presence in the industry.
Key Insight: Netherlands demonstrates strong market positioning with an average shipment value of $87.7M, indicating premium pricing strategy compared to the market average of $78.5K.
Netherlands is a key market for Gliclazide imports, representing 29.2% of total trade value.
3Vietnam
Vietnam emerges as the third largest importing country, achieving a total trade value of $41.8M through 77 shipments. This represents a market share of 13.9% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Vietnam has a diverse importer base, with their top importers including:
• DANANG PHARMACEUTICAL MEDICAL EQUIP - $31.3M (74.8% of country's total business)
• DELTA IMPORT EXPORT MEDICAL CO., LT - $3.4M (8.2% of country's total business)
• CENTRAL PHARMACEUTICAL JOINT STOCK - $3.2M (7.8% of country's total business)
• SOHACO TRADING AND PHARMACEUTICAL - $1.3M (3.2% of country's total business)
Key Insight: Vietnam demonstrates strong market positioning with an average shipment value of $542.8K, indicating premium pricing strategy compared to the market average of $78.5K.
Vietnam is a key market for Gliclazide imports, representing 13.9% of total trade value.
4Brazil
Brazil emerges as the fourth largest importing country, achieving a total trade value of $20.7M through 408 shipments. This represents a market share of 6.9% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Brazil has a diverse importer base, with their top importers including:
• TORRENT DO BRASIL LTDA - $6.5M (31.6% of country's total business)
• M/S. RANBAXY FARMACEUTICA LTDA : - $2.4M (11.7% of country's total business)
• RANBAXY FARMACEUTICA LTDA : - $2.3M (11.0% of country's total business)
• TORRENT DO BRASIL LIMITEDA - $1.6M (7.8% of country's total business)
Key Insight: Brazil demonstrates strong market positioning with an average shipment value of $50.7K, indicating competitive pricing strategy compared to the market average of $78.5K.
Brazil is a key market for Gliclazide imports, representing 6.9% of total trade value.
5Philippines
Philippines emerges as the fifth largest importing country, achieving a total trade value of $8.3M through 0 shipments. This represents a market share of 2.8% of the total market activity, demonstrating their significant presence in the industry.
Key Insight: Philippines demonstrates strong market positioning with an average shipment value of $8.3M, indicating premium pricing strategy compared to the market average of $78.5K.
Philippines is a key market for Gliclazide imports, representing 2.8% of total trade value.
Buyer Segment Analysis
TransData Nexus Gliclazide buyer market intelligence
1Buyer Segment Analysis
The importation of Gliclazide from India involves various buyer segments, each with distinct purchasing behaviors:
- Distributors: Entities like MYLAN HUNGARY KFT (Hungary) and FIEGE HEALTHCARE LOGISTICS GMBH (Germany) function as intermediaries, procuring large quantities to supply regional markets. Their purchasing patterns are characterized by bulk orders to ensure consistent supply chains.
- Contract Manufacturers: Companies such as TORRENT DO BRASIL LTDA (Brazil) and RANBAXY FARMACEUTICA LTDA (Brazil) import Gliclazide for formulation and packaging under their brand names. Their procurement is aligned with production schedules and market demand forecasts.
- Government Procurement Agencies: Entities like CENTRAL PHARMACEUTICAL JOINT STOCK (Vietnam) and DELTA IMPORT EXPORT MEDICAL CO., LTD (Vietnam) are involved in national tenders to supply public healthcare facilities. Their purchasing is influenced by government healthcare policies and budget allocations.
- Retail Chains and Hospital Groups: Organizations such as MEDREICH PLC (United Kingdom) and MYLAN PHARMACEUTICALS ULC (Canada) procure Gliclazide to meet the needs of their retail outlets and affiliated hospitals. Their orders are typically based on patient demand and inventory turnover rates.
Understanding these segments is crucial for tailoring marketing strategies and ensuring efficient supply chain management.
Country-Specific Import Regulations
TransData Nexus Gliclazide buyer market intelligence
1Country-Specific Import Regulations
The top five importing countries have specific regulatory frameworks for Gliclazide:
- Hungary:
- Regulatory Authority: National Institute of Pharmacy and Nutrition (OGYÉI).
- Import Registration: Requires submission of a marketing authorization application, including quality, safety, and efficacy data.
- Timeline: Approximately 210 days.
- Import Tariff: Pharmaceutical products under HS Code 30049099 are generally exempt from import duties within the EU.
- Netherlands:
- Regulatory Authority: Medicines Evaluation Board (CBG-MEB).
- Import Registration: Submission of a marketing authorization dossier in line with EU directives.
- Timeline: Around 210 days.
- Import Tariff: No import duties for pharmaceutical products under HS Code 30049099 within the EU.
- Vietnam:
- Regulatory Authority: Drug Administration of Vietnam (DAV).
- Import Registration: Requires a registration dossier, including clinical data and Good Manufacturing Practice (GMP) certification.
- Timeline: Approximately 12 months.
- Import Tariff: Pharmaceuticals under HS Code 30049099 are subject to a 5% import duty.
- Brazil:
- Regulatory Authority: National Health Surveillance Agency (ANVISA).
- Import Registration: Submission of a comprehensive dossier, including clinical trials and GMP certification.
- Timeline: Around 12 months.
- Import Tariff: Pharmaceutical products under HS Code 30049099 are subject to a 14% import duty.
- Philippines:
- Regulatory Authority: Food and Drug Administration Philippines (FDA).
- Import Registration: Requires a Certificate of Product Registration (CPR) with supporting documents.
- Timeline: Approximately 6 months.
- Import Tariff: Pharmaceuticals under HS Code 30049099 are subject to a 5% import duty.
Compliance with these regulations is essential for market entry and sustained operations.
Demand Drivers & Market Opportunity
TransData Nexus Gliclazide buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for Gliclazide is primarily driven by the global prevalence of type 2 diabetes, which has been increasing steadily. According to the International Diabetes Federation, as of 2025, approximately 578 million adults worldwide are living with diabetes, with type 2 diabetes accounting for the majority of cases. This rising prevalence underscores the need for effective oral hypoglycemic agents like Gliclazide.
Government healthcare programs and the expansion of universal health coverage have also significantly influenced demand. Many countries have included Gliclazide in their national essential medicines lists, aligning with the World Health Organization's Model List of Essential Medicines, which recommends Gliclazide for the management of type 2 diabetes. Additionally, tender-based procurement systems are prevalent, especially in low- and middle-income countries, facilitating bulk purchasing and ensuring wider accessibility. The presence of 643 buyers across 109 countries, as per our data, reflects the extensive global reach and market opportunity for Gliclazide.
Common Questions — Gliclazide Buyers & Importers
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
QWho is the largest gliclazide buyer importing from India?
Based on import volume and value, MYLAN HUNGARY KFT, (HUNGARY) leads with $87.1M in imports and a 28.9% market share — the highest of any single gliclazide importer. DANANG PHARMACEUTICAL MEDICAL EQUIP (VIETNAM) and TORRENT DO BRASIL LTDA (BRAZIL) are the next largest buyers.
QHow many companies buy gliclazide from India?
There are 643 active gliclazide buyers importing from India, with a combined market of $300.8M across 3,830 shipments to 109 countries. The top 5 buyers hold 44.0% of total import value, while the remaining 638 buyers handle the other 56.0%.
QWhich countries import the most gliclazide from India?
The top importing countries for gliclazide from India are Hungary (29.3%), Netherlands (29.2%), Vietnam (13.9%), Brazil (6.9%), Philippines (2.8%). These markets represent the largest demand centres for Indian pharmaceutical exports of gliclazide, with buyers ranging from government procurement agencies to private pharmaceutical distributors.
QWhat is the average import order value for gliclazide from India?
The average import transaction value for gliclazide from India is $78.5K, with an average unit price of $6.75 per unit. Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.
Buyer Segment Analysis
TransData Nexus Gliclazide buyer market intelligence
1Buyer Segment Analysis
The importation of Gliclazide from India involves various buyer segments, each with distinct purchasing behaviors:
- Distributors: Entities like MYLAN HUNGARY KFT (Hungary) and FIEGE HEALTHCARE LOGISTICS GMBH (Germany) function as intermediaries, procuring large quantities to supply regional markets. Their purchasing patterns are characterized by bulk orders to ensure consistent supply chains.
- Contract Manufacturers: Companies such as TORRENT DO BRASIL LTDA (Brazil) and RANBAXY FARMACEUTICA LTDA (Brazil) import Gliclazide for formulation and packaging under their brand names. Their procurement is aligned with production schedules and market demand forecasts.
- Government Procurement Agencies: Entities like CENTRAL PHARMACEUTICAL JOINT STOCK (Vietnam) and DELTA IMPORT EXPORT MEDICAL CO., LTD (Vietnam) are involved in national tenders to supply public healthcare facilities. Their purchasing is influenced by government healthcare policies and budget allocations.
- Retail Chains and Hospital Groups: Organizations such as MEDREICH PLC (United Kingdom) and MYLAN PHARMACEUTICALS ULC (Canada) procure Gliclazide to meet the needs of their retail outlets and affiliated hospitals. Their orders are typically based on patient demand and inventory turnover rates.
Understanding these segments is crucial for tailoring marketing strategies and ensuring efficient supply chain management.
Country-Specific Import Regulations
TransData Nexus Gliclazide buyer market intelligence
1Country-Specific Import Regulations
The top five importing countries have specific regulatory frameworks for Gliclazide:
- Hungary:
- Regulatory Authority: National Institute of Pharmacy and Nutrition (OGYÉI).
- Import Registration: Requires submission of a marketing authorization application, including quality, safety, and efficacy data.
- Timeline: Approximately 210 days.
- Import Tariff: Pharmaceutical products under HS Code 30049099 are generally exempt from import duties within the EU.
- Netherlands:
- Regulatory Authority: Medicines Evaluation Board (CBG-MEB).
- Import Registration: Submission of a marketing authorization dossier in line with EU directives.
- Timeline: Around 210 days.
- Import Tariff: No import duties for pharmaceutical products under HS Code 30049099 within the EU.
- Vietnam:
- Regulatory Authority: Drug Administration of Vietnam (DAV).
- Import Registration: Requires a registration dossier, including clinical data and Good Manufacturing Practice (GMP) certification.
- Timeline: Approximately 12 months.
- Import Tariff: Pharmaceuticals under HS Code 30049099 are subject to a 5% import duty.
- Brazil:
- Regulatory Authority: National Health Surveillance Agency (ANVISA).
- Import Registration: Submission of a comprehensive dossier, including clinical trials and GMP certification.
- Timeline: Around 12 months.
- Import Tariff: Pharmaceutical products under HS Code 30049099 are subject to a 14% import duty.
- Philippines:
- Regulatory Authority: Food and Drug Administration Philippines (FDA).
- Import Registration: Requires a Certificate of Product Registration (CPR) with supporting documents.
- Timeline: Approximately 6 months.
- Import Tariff: Pharmaceuticals under HS Code 30049099 are subject to a 5% import duty.
Compliance with these regulations is essential for market entry and sustained operations.
Demand Drivers & Market Opportunity
TransData Nexus Gliclazide buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for Gliclazide is primarily driven by the global prevalence of type 2 diabetes, which has been increasing steadily. According to the International Diabetes Federation, as of 2025, approximately 578 million adults worldwide are living with diabetes, with type 2 diabetes accounting for the majority of cases. This rising prevalence underscores the need for effective oral hypoglycemic agents like Gliclazide.
Government healthcare programs and the expansion of universal health coverage have also significantly influenced demand. Many countries have included Gliclazide in their national essential medicines lists, aligning with the World Health Organization's Model List of Essential Medicines, which recommends Gliclazide for the management of type 2 diabetes. Additionally, tender-based procurement systems are prevalent, especially in low- and middle-income countries, facilitating bulk purchasing and ensuring wider accessibility. The presence of 643 buyers across 109 countries, as per our data, reflects the extensive global reach and market opportunity for Gliclazide.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Buyer Identification: 643 global importers of Gliclazide identified from consignee fields in DGFT shipping bill records.
- 2.Import Value Analysis: Total import value aggregated from 3,830 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Geographic Distribution: Buyer imports distributed across 109 destination countries with market share per buyer calculated from capped values.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
3,830 Verified Shipments
643 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists